{"id":"W2127435768","doi":"10.1586/erc.11.21","title":"Dabigatran for stroke prevention in atrial fibrillation: the RE-LY trial","year":2011,"lang":"en","type":"article","venue":"Expert Review of Cardiovascular Therapy","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hamilton General Hospital","funders":"","keywords":"Medicine; Dabigatran; Warfarin; Atrial fibrillation; Stroke (engine); Rivaroxaban; Cardiology; Internal medicine; Discovery and development of direct thrombin inhibitors; Embolism; Anesthesia; Randomized controlled trial; Direct thrombin inhibitor; Thrombin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001126095,0.000530725,0.001580253,0.0002070353,0.0001369043,0.0007286622,0.0003796183,0.0009624514,0.004496258],"category_scores_gemma":[0.001593464,0.0001197595,0.001322564,0.0003763814,0.0001643264,0.0004720699,0.000292934,0.002080519,0.0006310832],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002865419,"about_ca_system_score_gemma":0.0006569708,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005795993,"about_ca_topic_score_gemma":0.001976341,"domain_scores_codex":[0.99954,0.000255274,0.00005016247,0.00004029749,0.00007714031,0.00003724038],"domain_scores_gemma":[0.9996461,0.0001390696,0.00009438552,0.00001636582,0.00004409679,0.00005996328],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1574794,0.001500693,0.004633248,0.05394553,0.01769354,0.0002957962,0.0001522357,0.001041057,0.002826964,0.007465588,0.08977223,0.6631938],"study_design_scores_gemma":[0.6318126,0.01824236,0.04350507,0.02594715,0.03447974,0.001239274,0.000206683,0.001620516,0.001462394,0.008310121,0.2330656,0.0001084988],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.05947148,0.91005,0.0006634036,0.01006082,0.002864202,0.0007382027,0.002678133,0.0000642126,0.01340946],"genre_scores_gemma":[0.2891593,0.671647,0.002612974,0.0142151,0.004252658,0.00219264,0.005212367,0.00003234732,0.01067562],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.004496258,"threshold_uncertainty_score":0.01504147,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1352088950558129,"score_gpt":0.3795011384208205,"score_spread":0.2442922433650076,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}